Navigation Links
Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
Date:11/16/2007

arly stage of product development; the significant costs to develop our products as all of our products are currently in development, preclinical studies or clinical trials; obtaining additional financing to support our operations and the development of our products; obtaining regulatory approval for our technologies; anticipated timing of regulatory filings and the potential success in gaining regulatory approval and complying with governmental regulations applicable to our business. Our business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended April 30, 2007 and quarterly report on Form 10-Q for the quarter ended July 31, 2007. The company cautions investors not to place undue reliance on the forward- looking statements contained in this press release. Peregrine Pharmaceuticals, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.

Contacts:

GendeLLindheim BioCom Partners

Investors Media

info@peregrineinc.com Barbara Lindheim

(800) 987-8256 (212) 918-4650


'/>"/>
SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... is a tiny period of time between the registration...our conscious recognition of it ― between th...t as an apple. Our minds lag behind our eyes, but ...s to the world around us? , Some estimates say...s say 500 milliseconds. A new study by Tel Aviv Un...
(Date:11/30/2009)... studies report safe transplant results in animals...-- Two new studies in animals suggest that stem ce... blood could help treat some lung and heart disord...cells can differentiate into a long list of differ... Park of the Samsung Medical Center in Seoul, Kore...
(Date:11/30/2009)..., SHORT HILLS, N.J., Nov. 30 Kem...hnologies, Inc. and OmniActive Health Technologies...tlement of their dispute. The parties agree that K... titled "Process for Isolation, Purification and R...d Oleoresin and Uses Thereof" and the reissues of ...
(Date:11/30/2009)... , NASHVILLE, Tenn., Nov. 30 /PRNewswire/ ... about gifts for the holidays. For a loved one wit...amily members and friends oftentimes struggle with...iving , one of the leading providers of senior liv...,s and dementia care , offers these suggestions. ,...
(Date:11/30/2009)... European Association of Urology (EAU) and Europa ...t against prostate cancer, have entered into an,a...ommitment to increase and improve,patient awarene..., Professor Per-Anders Abrahamsson, Secretary-Gen...iated partnership, Europa Uomo will gain access to...
Breaking Medicine News(10 mins):Health News:Now you see it, now you know you see it 2Health News:Gift Ideas for Loved Ones with Alzheimer's/Dementia 2
...REE, Mass., Dec. 15 As the busiest weeks of the,h...el their best. According to,Bruce Fisher, veteran ...-service salon and spa in Braintree, MA there are ...ts or,hosting a gathering for family and friends a...
...ure better at detecting problems on left side of c...lthDay News) -- While a colonoscopy is a very effe...t may not be quite as good as previously thought, ...t as effective at spotting potential problems of t...
...l advances, not lifestyle changes, are source of t...15 (HealthDay News) -- U.S. death rates for heart ...t since 1999, according to the latest American Hea...n,t done, since the major risk factors for heart d...
...XANDRIA, VA, December 15 2008 The American Physic...ith musculoskeletal pain to consider treatment by ...rvey showing that more than one-third of American ...rvey of more than 32,000 Americans were released D...
... Louis, Dec. 15, 2008 A program at Washington Uni...uis Children,s Hospital designed to increase aware...of blood donations within the African-American fai...y launched in 2003 by Michael R. DeBaun, M.D., pro...
... and Replaces Expiring Registration Statement , ...P Corporation (NYSE: AGP ) announced today that ...on Form S-3 with the Securities and Exchange Commi... stock and other securities at prices and on terms...
Other Medicine News:Health News:Just in Time for the Holiday Rush, Braintree Stylist Bruce Fisher Offers Holiday Style & Beauty Tips 2Health News:Colonoscopy Has a 'Right Side' Blind Spot 2Health News:Colonoscopy Has a 'Right Side' Blind Spot 3Health News:Deaths From Heart Disease, Stroke Down 30% 2Health News:Deaths From Heart Disease, Stroke Down 30% 3Health News:Physical therapy offers evidence-based solution to musculoskeletal pain 2Health News:Church effort sharply increases first-time African-American blood donors 2Health News:AMERIGROUP Files Shelf Registration Statement 2
(Date:11/30/2009)...NCETON, N.J., Nov. 30 Co...will present at the Piper Jaffray 21st Annual Heal...at 1:30 p.m. (ET). Investors may access a live we...n order to register and download any necessary sof...ce, with headquarters in Princeton, New Jersey, is...
(Date:11/30/2009)..., NEW YORK, Nov. 30 Reportlinker.... available in its catalogue: ,, Cardiac Defibr... ,, http://www.reportlinker.com/p0164315/Cardi...e-Report.html ,, Cardiovascular disease (CVD).... Sudden cardiac arrest survivors are prone to arr...
(Date:11/30/2009)...LAUREL, N.J., Nov. 30 Me...f technology-enabled clinical documentation servic...t with Nuance Communications, Inc. (Nuance) under ...ic speech recognition engine and processing softwa...Quist,s front-end speech recognition application f...
Breaking Medicine Technology:Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8MedQuist Signs Agreement Extending Use of Real-Time Speech Recognition Engine to Wide Range of Medical Specialties 2NeoGenomics To Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 18 2009 14813 1NeoGenomics To Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 18 2009 14813 2NQF Helps Ensure Health IT Captures Information to Drive Quality Improvement 6214 1NQF Helps Ensure Health IT Captures Information to Drive Quality Improvement 6214 2NQF Helps Ensure Health IT Captures Information to Drive Quality Improvement 6214 3Gary Wenzel Named President TBWA WorldHealth 6209 1Gary Wenzel Named President TBWA WorldHealth 6209 2Gary Wenzel Named President TBWA WorldHealth 6209 3
...2007 /PRNewswire-FirstCall/ -- Vical,Incorporated ...ted,with the company,s Vaxfectin(TM) adjuvant elic...in juvenile (1 - 2 year old),nonhuman primates con...more than one year after vaccination, and steriliz...disease and no,detectable virus after challenge. I...
..., May 31, 2007 /PRNewswire-FirstCall/ -- Alexza,Ph...resent at the,49th Annual American Headache Societ...l of Staccato(R) prochlorperazine (AZ-001),for the...presentation, "Efficacy and tolerability profile o...ith migraine headache",(Poster S-72), will be avai...
Other Medicine Technology:Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 2Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 3Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 4Alexza Pharmaceuticals to Present AZ-001 Phase IIb Clinical Data at,the American Headache Society Meeting 2
...ve largely replaced the use of plates and screws i... rods or pins in the forearm or ankle is not a new...he pins or hold them in place. A common worry asso...mplant. The SST® (Stainless Steel Taper) is th...
Epic™ HF ICD
Biomet Low Profile Tibial Nail
Charlotte Shoulder™ System
Medicine Products: